A laser-cutting-based manufacturing process for the generation of three-dimensional scaffolds for tissue engineering...

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Regenerative Medicine

Background:

• Developing advanced biomaterials is crucial for effective tissue engineering.
• Polycaprolactone/Hydroxyapatite (PCL/HA) composites offer promising properties for bone regeneration.
• Existing scaffold fabrication methods face limitations in precision and scalability.

Purpose of the Study:

• To develop a reliable and high-resolution manufacturing process for sheet-based stacked scaffolds (SSCs) using laser-cutting (LC).
• To evaluate the processability of PCL/HA composite materials and the structural characteristics of the resulting scaffolds.
• To assess the biocompatibility and osteogenic potential of the manufactured PCL/HA SSCs using human mesenchymal stem cells.

Main Methods:

• A laser-cutting (LC) technique was employed to fabricate sheet-based stacked scaffolds (SSCs) from Polycaprolactone/Hydroxyapatite (PCL/HA) composite foils.
• The process involved cutting individual sheets and stacking them to create scaffolds with controlled pore sizes.
• The influence of laser power on material processability and structural accuracy was investigated, with pore sizes down to 40 µm and solid structures down to 125 µm achieved.

Main Results:

• The laser-cutting process demonstrated high reproducibility for PCL/HA composite materials with up to 50% hydroxyapatite content.
• Scaffold accuracy was dependent on laser power, enabling the creation of structures with defined pore sizes (approx. 40 µm) and stable solid elements (approx. 125 µm).
• Human mesenchymal stem cells (SCP-1) cultured on PCL/HA SSCs exhibited natural morphology and differentiated into functional osteoblasts.

Conclusions:

• The developed laser-cutting method for generating PCL/HA SSCs provides a reliable, fast, and high-resolution approach for tissue engineering applications.
• This SSC fabrication technique facilitates cell seeding and analysis within 3D cultures, enabling the generation of functional tissue constructs.
• The PCL/HA SSCs demonstrate excellent biocompatibility and osteogenic potential, offering new possibilities for bone regenerative therapies.